Eli Lilly led a $100 million funding round for Absci, contributing $40 million to develop ABS-201, an injectable treatment for baldness. The funding aims to enhance their direct-to-consumer ambitions in the growing injectable market.
Amount Raised
$40 Million
Round Type
Funding Round
VancouverManufacturingBiotechnologyHealth CareArtificial IntelligenceTherapeuticsBiopharmaInvestors
Description
Eli Lilly invested $40 million in Absci as part of a $100 million funding round. The funds will be used to advance the development of ABS-201, an injectable antibody targeting baldness and endometriosis. Lilly's investment positions them closely with Absci in the competitive AI drug discovery space. This deal coincides with the release of positive safety data for ABS-201, spotlighting a significant market opportunity.
Quick answer
AbSci Corp raised $40 Million in a Funding Round round, dated July 1, 2026. Investors: Adage, BVF Partners, Columbia Threadneedle, Invus, Redmile and Eli Lilly. AbSci Corp is based in Vancouver, Washington, United States.
- How much did AbSci Corp raise?
- AbSci Corp raised $40 Million in a Funding Round round on July 1, 2026.
- Who invested in AbSci Corp?
- Adage, BVF Partners, Columbia Threadneedle, Invus, Redmile and Eli Lilly are named as investors in this round.
- What does AbSci Corp do?
- Absci is a generative AI drug creation company.
- Where is AbSci Corp based and how big is it?
- AbSci Corp is based in Vancouver, Washington, United States.
- Who are the decision-makers at AbSci Corp?
- Fundz holds 2 contacts at AbSci Corp, including the Chief Legal Officer, Absci. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as AbSci Corp that raised within 45 days of this round, from Fundz verified event records.
- Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
- Apollomics raised $10M on August 14, 2026.
- Vaderis Therapeutics raised $152M (Series B) on August 11, 2026.
- Os Therapies raised $5M on August 10, 2026.
- Acasti raised $10M on August 4, 2026.
- HCW Biologics raised $1.5M (Post-IPO Equity) on July 29, 2026.
Who to call at AbSci Corp, and when
A new round usually means AbSci Corp is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AbSci Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbSci Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbSci Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbSci Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AbSci Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.